Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | KPTIQKaryopharm Therapeutics Inc.FY2025 · Dec |
|---|---|
| Revenue | $146.07M |
| Revenue, yoy | +0.6% |
| Net income | $196.04M |
| Net income, yoy | −156.5% |
| Net margin | -134.2% |
| Free cash flow | $75.37M |
| FCF margin | -51.6% |
| EPS, diluted | $17.93 |
Add another company.